HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anastasios Georgoulis Selected Research

Anastasios Georgoulis Research Topics

Disease

1Cardiotoxicity
03/2024
1Ischemia
01/2021
1Infarction (Infarctions)
01/2021
1Reperfusion Injury
01/2021
1Necrosis
04/2020
1Genomic Instability
09/2017
1Carcinogenesis
09/2017
1Breast Neoplasms (Breast Cancer)
12/2012
1Neoplasm Metastasis (Metastasis)
12/2012
1Neoplasms (Cancer)
12/2012
1Acquired Immunodeficiency Syndrome (AIDS)
06/2012
1Osteoarthritis
06/2012
1Arthritis (Polyarthritis)
06/2012
1Infections
06/2012

Drug/Important Bio-Agent (IBA)

1pembrolizumabIBA
03/2024
1Immune Checkpoint InhibitorsIBA
03/2024
1Atorvastatin (Lipitor)FDA Link
03/2024
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
01/2021
1WortmanninIBA
01/2021
1AntioxidantsIBA
01/2021
1oleuropeinIBA
01/2021
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2021
1A-factor (Streptomyces)IBA
04/2020
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
09/2017
1Integrin alphaVbeta3IBA
12/2012
1LigandsIBA
12/2012
1Peptides (Polypeptides)IBA
12/2012
1glycyl- arginyl- glycyl- aspartyl- seryl- prolineIBA
12/2012
1arginyl-glycyl-aspartic acidIBA
12/2012
1Actins (F Actin)IBA
12/2012
1GelatinasesIBA
06/2012
1GelatinIBA
06/2012
1Tissue Inhibitor of Metalloproteinase-1IBA
06/2012
1Matrix Metalloproteinases (MMPs)IBA
06/2012
1Metalloproteases (Metalloproteinases)IBA
06/2012

Therapy/Procedure

1Therapeutics
03/2024